There were 1,853 press releases posted in the last 24 hours and 399,358 in the last 365 days.

Pain Therapeutics Conference - Latest updates on developments in targeting nerve growth factors

SMi’s 15th annual Pain Therapeutics conference will be taking place on the 18th - 19th May 2015 in London, UK. Book by 27th February to save £300

LONDON, ENGLAND, UNITED KINGDOM, February 12, 2015 /EINPresswire.com/ -- SMi’s Pain Therapeutics conference is a must attend event for attendees who want to benchmark their organisation with recent developments in the pain therapeutics arena and methods on how to overcome the challenges faced. The conference will examine principles and illustrative case studies on current activities and trends in clinical and pre-clinical evidence-based and best-practice-based pain medicine.

Benefits of Attending Include:

• New for 2015 - Presentations on personalized medicine for pain, biomarkers and CGRP receptor antagonists for migraine treatment
• Learn about Grunenthal’s latest screening approach for neuropathic pain and pain models
• Hear timely case studies from Merck and Afferent Pharmaceuticals
• Spotlight sessions - Latest updates on developments in targeting nerve growth factors
• Discover latest advances in the treatment of pain from leading, pharma, biotech and academic experts from the industry
• Interactive panel discussion the reviewing validity of animal models for chronic pain

KEY SPEAKERS INCLUDE:

• Professor Anthony Jones, Professor of Neuro-Rheumatology, Human Pain Research Group, University of Manchester
• Professor Richard Knowles, CEO, Arachos Pharma
• Dr Emanuele Sher, Senior Research Advisor, Neuroscience, Discovery, Lilly Research Centre, Eli Lilly
• Dr Anthony P. Ford, Chief Scientific Officer, Afferent Pharmaceuticals
• Dr Richard Butt, Senior Director, Research Project Leader, Clinical Research, Pfizer
• Dr Shahnaz Yusaf, Investigator Biopharm Innovation BDU, GlaxoSmithKline
• Dr Ian Bell, Principal Scientist, Discovery Chemistry, Merck
• Dr Mark T. Brown, MD, Executive Director, Clinical Program Leader for Osteoarthritis and Cancer Pain Studies, Pfizer Inc
• Dr Gregor Bahrenberg, Associate Scientific Director, Grunenthal

Pain Therapeutics is sponsored by: CHDR & PRA Health Sciences

Book by 27th February to save £300

For more information or to register visit http://www.smi-online.co.uk/2015pain-therapeutics18.asp
Alternatively, contact Magdalena Georgieva on +44 (0)20 7827 6148 or email mgeorgieva@smi-online.co.uk

--------------- END ---------------

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Margaret Mugema
SMi Group Ltd
+44 (0) 20 7827 6072
email us here